Previous Article | Next Article ![]()
Journal of Clinical Microbiology, August 1998, p. 2248-2253, Vol. 36, No. 8
Department of
Pediatrics1 and
Department of Medical
Microbiology & Infectious Diseases,3 Erasmus
Medical Center Rotterdam, Erasmus University Rotterdam, 3000 DR
Rotterdam, The Netherlands, and
Department of Pediatrics,
Division of Infectious Diseases, School of Medicine and Biomedical
Sciences, Buffalo, New York2
Received 26 January 1998/Returned for modification 9 April
1998/Accepted 5 May 1998
Pneumococcal colonization was studied in 19 children monitored from
birth through the age of 2 years. For this purpose, pneumococcal isolates were characterized by capsular typing, restriction fragment end labeling (RFEL), and penicillin-binding protein (PBP) genotyping. Fifty-eight isolates were collected and were found to belong to 10 capsular types, 31 RFEL types, and 7 PBP genotypes. Thirty-nine percent
of the isolates had reduced susceptibility to penicillin. All seven highly resistant strains (MICs, >1 µg/ml) were identical to the pandemic clone 23F. Children were culture positive
between one and eight times at 13 scheduled visits. Although the
infants were frequently recolonized with different strains,
colonization with one particular strain often persisted for
several months. Isolation of a previously detected capsular type was
common, and the chromosomal homogeneity tended to be high when it
occurred. Horizontal transfer of capsular genes between strains
of different RFEL types was demonstrated in one child. The
ecological advantage of transfer of capsular genes is
unclear unless survival of the organism on a mucosal surface may be
linked to immunoprotective pressure against particular capsular types.
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Molecular Characterization of Pneumococcal Nasopharynx Isolates
Collected from Children during Their First 2 Years of Life
*
Corresponding author. Mailing address: Laboratory of
Pediatrics/Room Ee 1500, Erasmus University Rotterdam, P.O. Box 1738, 3000 DR Rotterdam, The Netherlands. Phone: 31-10-4088224. Fax: 31-10-4365053. E-mail: hermans{at}kgk.fgg.eur.nl.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|